East Penn RheumatologyAssociates, P.C.
Bethlehem, Pennsylvania 18105
0 studies enrolling now · 25 studies all time
What they study most
Arthritis, Arthritis, Psoriatic, Arthritis, Rheumatoid, Fibromyalgia, Low Back Pain, Lupus, Lupus Erythematosus, Systemic, Osteoarthritis, Osteoarthritis, Hip, Peripheral Vascular Disease, Primary Sjogrens Disease, Psoriatic Arthritis
Studies at this site
- The Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis — Completed
- A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome — Running, not enrolling
- Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis — Completed
- Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate — Completed
- Psoriatic Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to NSAIDs or Non-biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) Therapy — Completed
- A Study of Tanezumab in Adults With Chronic Low Back Pain — Completed
- Extension Study Of Tanezumab In Osteoarthritis — Stopped early
- Tanezumab in Osteoarthritis of the Knee — Completed
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen — Completed
- Tanezumab in Osteoarthritis Of The Hip — Completed
- Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients — Completed
- Study to Assess Safety and Efficacy of Filgotinib, Lanraplenib and Tirabrutinib in Adults With Active Sjogren's Syndrome — Completed
- Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis — Completed
- Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis — Completed
- Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus — Completed
- A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus — Completed
- A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT) — Stopped early
- Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis — Completed
- PF-00489791 For The Treatment Of Raynaud's — Completed
- A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background Methotrexate — Completed
- Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors — Completed
- A Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid Arthritis — Completed
- A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis — Completed
- A Long-Term, Placebo-Controlled X-Ray Study Investigating the Safety and Efficacy of SD-6010 in Subjects With Osteoarthritis of the Knee — Completed
- Abatacept Versus Adalimumab Head-to-Head — Completed